As of April 16, 2025, Disc Medicine (IRON) has a market cap of $1.43 billion USD. According to our data, Disc Medicine is ranked No.4509 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.43 B |
-34.31%
|
Dec 31, 2024 | $2.17 B |
9.76%
|
Dec 29, 2023 | $1.98 B |
190.40%
|
Dec 30, 2022 | $0.68 B |
-77.22%
|
Dec 31, 2021 | $2.99 B |
-73.55%
|
Dec 31, 2020 | $11.32 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Agios Pharmaceuticals
AGIO
|
$1.59 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Ironwood Pharmaceuticals
IRWD
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.70 B |
0.000 M
|
![]() USA
|
![]() BioCryst Pharmaceuticals
BCRX
|
$1.55 B |
-0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
Market Cap | = | IRON Stock Price | * | IRON Shares Outstanding |
= | $41.31 | * | 34.57 M | |
= | $1.43 B |